Cargando…
The anti-inflammatory effect of LMWF5A and N-acetyl kynurenine on macrophages: Involvement of aryl hydrocarbon receptor in mechanism of action
After a traumatic insult, macrophages can become activated leading to general inflammation at the site of injury. Activated macrophages are partially regulated by the aryl hydrocarbon receptor (AhR) which when activated suppresses inflammation by limiting the secretion of pro-inflammatory cytokines...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068081/ https://www.ncbi.nlm.nih.gov/pubmed/30073204 http://dx.doi.org/10.1016/j.bbrep.2018.06.006 |
_version_ | 1783343204511252480 |
---|---|
author | Rael, Leonard T. Bar-Or, Raphael Banton, Kaysie L. Mains, Charles W. Roshon, Michael Tanner, Allen H. Lieser, Mark J. Acuna, David L. Bar-Or, David |
author_facet | Rael, Leonard T. Bar-Or, Raphael Banton, Kaysie L. Mains, Charles W. Roshon, Michael Tanner, Allen H. Lieser, Mark J. Acuna, David L. Bar-Or, David |
author_sort | Rael, Leonard T. |
collection | PubMed |
description | After a traumatic insult, macrophages can become activated leading to general inflammation at the site of injury. Activated macrophages are partially regulated by the aryl hydrocarbon receptor (AhR) which when activated suppresses inflammation by limiting the secretion of pro-inflammatory cytokines and promoting the over expression of immuno-modulatory mediators. This study aims to determine whether the low molecular weight fraction of 5% human serum albumin (LMWF5A) and N-acetyl kynurenine (NAK), an N-acetyl tryptophan (NAT) breakdown product in LMWF5A, can regulate inflammation by inhibiting macrophage activation through the AhR since kynurenine is a known AhR agonist. Using LCMS, we demonstrate that NAT is non-enzymatically degraded during accelerated aging of LMWF5A with high heat accelerating degradation. More importantly, NAK is a major degradation product found in LMWF5A. THP-1 monocytes were differentiated into macrophages using phorbol 12-myristate 13-acetate (PMA) and pre-treated with 2-fold dilutions of LMWF5A or synthetic NAK with or without an AhR antagonist (CH223191) prior to overnight stimulation with lipopolysaccharide (LPS). Treatment with LMWF5A caused a 50–70% decrease in IL-6 release throughout the dilution series. A dose-response inhibition of IL-6 release was observed for NAK with maximal inhibition (50%) seen at the highest NAK concentration. Finally, an AhR antagonist partially blocked the anti-inflammatory effect of LMWF5A while completely blocking the effect of NAK. A similar inhibitory effect was observed for CXCL-10, but the AhR antagonist was not effective suggesting additional mechanisms for CXCL-10 release. These preliminary findings suggest that LMWF5A and NAK partially promote the suppression of activated macrophages via the AhR receptor. Therefore, LMWF5A, which contains NAK, is potentially a useful therapeutic in medical conditions where inflammation is prevalent such as trauma, sepsis, and wound healing. |
format | Online Article Text |
id | pubmed-6068081 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-60680812018-08-02 The anti-inflammatory effect of LMWF5A and N-acetyl kynurenine on macrophages: Involvement of aryl hydrocarbon receptor in mechanism of action Rael, Leonard T. Bar-Or, Raphael Banton, Kaysie L. Mains, Charles W. Roshon, Michael Tanner, Allen H. Lieser, Mark J. Acuna, David L. Bar-Or, David Biochem Biophys Rep Research Article After a traumatic insult, macrophages can become activated leading to general inflammation at the site of injury. Activated macrophages are partially regulated by the aryl hydrocarbon receptor (AhR) which when activated suppresses inflammation by limiting the secretion of pro-inflammatory cytokines and promoting the over expression of immuno-modulatory mediators. This study aims to determine whether the low molecular weight fraction of 5% human serum albumin (LMWF5A) and N-acetyl kynurenine (NAK), an N-acetyl tryptophan (NAT) breakdown product in LMWF5A, can regulate inflammation by inhibiting macrophage activation through the AhR since kynurenine is a known AhR agonist. Using LCMS, we demonstrate that NAT is non-enzymatically degraded during accelerated aging of LMWF5A with high heat accelerating degradation. More importantly, NAK is a major degradation product found in LMWF5A. THP-1 monocytes were differentiated into macrophages using phorbol 12-myristate 13-acetate (PMA) and pre-treated with 2-fold dilutions of LMWF5A or synthetic NAK with or without an AhR antagonist (CH223191) prior to overnight stimulation with lipopolysaccharide (LPS). Treatment with LMWF5A caused a 50–70% decrease in IL-6 release throughout the dilution series. A dose-response inhibition of IL-6 release was observed for NAK with maximal inhibition (50%) seen at the highest NAK concentration. Finally, an AhR antagonist partially blocked the anti-inflammatory effect of LMWF5A while completely blocking the effect of NAK. A similar inhibitory effect was observed for CXCL-10, but the AhR antagonist was not effective suggesting additional mechanisms for CXCL-10 release. These preliminary findings suggest that LMWF5A and NAK partially promote the suppression of activated macrophages via the AhR receptor. Therefore, LMWF5A, which contains NAK, is potentially a useful therapeutic in medical conditions where inflammation is prevalent such as trauma, sepsis, and wound healing. Elsevier 2018-07-11 /pmc/articles/PMC6068081/ /pubmed/30073204 http://dx.doi.org/10.1016/j.bbrep.2018.06.006 Text en © 2018 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Research Article Rael, Leonard T. Bar-Or, Raphael Banton, Kaysie L. Mains, Charles W. Roshon, Michael Tanner, Allen H. Lieser, Mark J. Acuna, David L. Bar-Or, David The anti-inflammatory effect of LMWF5A and N-acetyl kynurenine on macrophages: Involvement of aryl hydrocarbon receptor in mechanism of action |
title | The anti-inflammatory effect of LMWF5A and N-acetyl kynurenine on macrophages: Involvement of aryl hydrocarbon receptor in mechanism of action |
title_full | The anti-inflammatory effect of LMWF5A and N-acetyl kynurenine on macrophages: Involvement of aryl hydrocarbon receptor in mechanism of action |
title_fullStr | The anti-inflammatory effect of LMWF5A and N-acetyl kynurenine on macrophages: Involvement of aryl hydrocarbon receptor in mechanism of action |
title_full_unstemmed | The anti-inflammatory effect of LMWF5A and N-acetyl kynurenine on macrophages: Involvement of aryl hydrocarbon receptor in mechanism of action |
title_short | The anti-inflammatory effect of LMWF5A and N-acetyl kynurenine on macrophages: Involvement of aryl hydrocarbon receptor in mechanism of action |
title_sort | anti-inflammatory effect of lmwf5a and n-acetyl kynurenine on macrophages: involvement of aryl hydrocarbon receptor in mechanism of action |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068081/ https://www.ncbi.nlm.nih.gov/pubmed/30073204 http://dx.doi.org/10.1016/j.bbrep.2018.06.006 |
work_keys_str_mv | AT raelleonardt theantiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction AT barorraphael theantiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction AT bantonkaysiel theantiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction AT mainscharlesw theantiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction AT roshonmichael theantiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction AT tannerallenh theantiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction AT liesermarkj theantiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction AT acunadavidl theantiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction AT barordavid theantiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction AT raelleonardt antiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction AT barorraphael antiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction AT bantonkaysiel antiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction AT mainscharlesw antiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction AT roshonmichael antiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction AT tannerallenh antiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction AT liesermarkj antiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction AT acunadavidl antiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction AT barordavid antiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction |